Clostridium difficile in urology

Annals of the Royal College of Surgeons of England

Volumn 90, Issue 1, 2008, Pages 36-39

  Hossain, M ^a   Crook, T J ^a   Keoghane, Stephen R ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Clostridium difficile; UK; Urology

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; ELDERLY CARE; FECES CULTURE; GASTROINTESTINAL INFECTION; HOSPITAL ADMISSION; HOSPITAL BED UTILIZATION; HOSPITAL DEPARTMENT; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RISK; LENGTH OF STAY; MEDICAL RECORD REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION; SURGICAL WARD; UNITED KINGDOM; URINARY TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; SURGICAL PROCEDURES, ELECTIVE; UROLOGIC DISEASES; UROLOGIC SURGICAL PROCEDURES;

EID: 38949143933     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588408X242358     Document Type: Article

References (26)

1. Health Protection Agency. Clostridium difficile cases rising, new figures show. [Accessed 29 August 2006].
2. Environmental Valuation & Cost-Benefit News. Lethal bug is costing NHS £160m a year - and is spreading at a phenomenal rate. [Accessed 29 August 2006].
3. Ambrose NS, Johnson M, Burdon DW, Keighly MRB. The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile. J Antimicrob Chemother 1985; 15: 319-26.
4. Aronnson B, Mollby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden 1980-1982. J Infect Dis 1985; 151: 476-81.
5. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 1997; 92: 739-50.
6. Brazier JS, Fitzgerald TC, Hosein I, Cefai C, Looker N, Walker M et al. Screening for carriage and nosocomial acquisition of Clostridium difficile by culture: a study of 284 admissions of elderly patients to six general hospitals in Wales. J Hosp Infect 1999; 43: 317-9.
7. McCoubrey J, Starr JM, Martin H, Poxton IR. Clostridium difficile: a prospective study in a geriatric unit. J Med Microbiol 2003; 52: 573-8
8. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992; 166: 561-7.
9. Portsmouth and South East Hampshire Guidelines and Medicines Management Committee. Antibiotic Prophylaxis in Surgery. Drug Therapy Guideline No 31.01 issued 05.05.04 [Accessed 17 August 2006].
10. Hall I, O'Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 1935; 49: 390.
11. Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978; i: 1063-6.
12. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978; 298: 531-4.
13. Health Protection Agency. Clostridium difficile yearly data January 2004 - December 2005. [Accessed 29 August 2006].
14. Thomas C, Stevenson M, Riley T. Antibiotics and hospitalized-acquired Clostridium difficile-associated diarrhea: a syetemic review. J Antimicrob Chemother 2003; 51: 1339-50.
15. Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993; 269: 71-5.
16. Bartlett JG. Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea or colitis. John Hopkins Med J 1981; 149: 6-9.
17. Kelly CP, Pothoulakis C, Lamont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257-62.
18. Bartlett J. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334-9.
19. Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005; 41: 1254-60.
20. Vesta KS, Wells PG, Gentry CA, Stipek WJ. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multi-center, case control evaluation. Am J Infect Control 2005; 33: 469-72.
21. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998; 40: 1-15.
22. Kent KC, Rubin MS, Wroblewski L, Hanff PA, Silen W. The impact of Clostridium difficile on a surgical service. Ann Surg 1998; 227: 296-301.
23. Modena S, Bearelly D, Swartz K, Friedenberg FK. Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study. Infect Control Hosp Epidemiol 2005; 26: 685-90.
24. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case control studies. Can Med Assoc J 2004; 171: 33-8.
25. Kyne L, Sougioultzis S, McFarland L, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002; 23: 653-9.
26. Barbut F, Petit JC. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 2001; 7: 405-10.